Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

Mise à jour : Il y a 4 ans
Référence : NCT00456833

Femme et Homme

Extrait

This study aims to assess the value of combined treatment with RAD001 and erlotinib in patients with advanced Non Small Cell Lung Cancer treated only with chemotherapy as systemic therapy.


Critère d'inclusion

  • non-small cell lung cancer


Liens